This author has yet to write their bio.
Meanwhile lets just say that we are proud jeremiah@devisedesigns.com contributed a whooping 7 entries.
Results from expanded cohort of ongoing DELTA-HF study show patients were decongested with stable renal function and with few rehospitalizations at 90 days following treatment eLym System recently received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) GALWAY, Ireland — Feb. 13, 2025 — WhiteSwell, a company pioneering a new paradigm in […]
https://onlinelibrary.wiley.com/doi/10.1002/ehf2.15192?af=R
https://link.springer.com/article/10.1007/s10741-024-10449-z
New vice president of clinical affairs and board of directors member will support advancement of eLym™ System therapy for acute decompensated heart failure GALWAY, Ireland — September 5, 2024 — WhiteSwell, a company pioneering a new paradigm in the treatment of acute decompensated heart failure (ADHF), today announced the appointments of Ric Cote to its […]
https://www.healio.com/news/cardiology/20240320/device-to-treat-acute-decompensated-heart-failure-feasible-safe-in-firstinhuman-study Key takeaways: Device-based thoracic duct decompression reduced congestion safely in patients with acute decompensated heart failure. The device targets congestion from the interstitial space, which diuretics mostly do not. Among patients with acute decompensated heart failure, device-based thoracic duct decompression demonstrated the ability to reduce congestion safely, according to results of a first-in-human study. […]
Patients were rehospitalized for heart failure less frequently in the six months following therapy GALWAY, Ireland — 6 March 2024 — WhiteSwell, a company pioneering a new paradigm in the treatment of acute decompensated heart failure (ADHF), announced today positive six-month follow-up data on the initial nine patients treated in its ongoing DELTA-HF trial evaluating […]
GALWAY, Ireland – 7 October 2023 – WhiteSwell, a company pioneering a new paradigm in the treatment of acute decompensated heart failure (ADHF), announced today positive initial results from its ongoing DELTA-HF trial evaluating the WhiteSwell eLym™ System. The data were presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2023 in […]
Parkmore Business Park West
Parkmore, Galway, H91 PTT8
Ireland
Connect Privacy Statement | Copyright © 2023
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlySettingsWe may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refuseing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.
If you do not want that we track your visit to our site you can disable tracking in your browser here:
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds:
You can read about our cookies and privacy settings in detail on our Privacy Policy Page.